TY  - GEN
AB  - Prescription opiate overdose is a leading cause of death among adults in the United States. If prescription opiates are the causative factor for multiple drug overdoses each year, then it would follow that naloxone needs to be distributed to both IV drug users and to prescription opiate users. However, while multiple organizations, including SAMHSA, now promote co-prescribing models  (wherein naloxone is consistently prescribed with all opiates), and consider it to be best practice, there are often significant barriers to implementing this practice.
AD  - Oregon Health and Science University
AU  - Bartholow, Lydia
DA  - 2016-07-01
DO  - 10.6083/M4CV4GTX
DO  - DOI
ED  - Scharf, Margaret
ED  - Advisor
ID  - 2994
KW  - Opioid-Related Disorders
KW  - Naloxone
KW  - Opiate Overdose
KW  - Drug Users
KW  - Cause of Death
KW  - Drug Prescriptions
L1  - https://digitalcollections.ohsu.edu/record/2994/files/3797_etd.pdf
L2  - https://digitalcollections.ohsu.edu/record/2994/files/3797_etd.pdf
L4  - https://digitalcollections.ohsu.edu/record/2994/files/3797_etd.pdf
LK  - https://digitalcollections.ohsu.edu/record/2994/files/3797_etd.pdf
N2  - Prescription opiate overdose is a leading cause of death among adults in the United States. If prescription opiates are the causative factor for multiple drug overdoses each year, then it would follow that naloxone needs to be distributed to both IV drug users and to prescription opiate users. However, while multiple organizations, including SAMHSA, now promote co-prescribing models  (wherein naloxone is consistently prescribed with all opiates), and consider it to be best practice, there are often significant barriers to implementing this practice.
PB  - Oregon Health and Science University
PY  - 2016-07-01
T1  - Identifying barriers in the implementation of a harm reduction program for opiate overdose
TI  - Identifying barriers in the implementation of a harm reduction program for opiate overdose
UR  - https://digitalcollections.ohsu.edu/record/2994/files/3797_etd.pdf
Y1  - 2016-07-01
ER  -